Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Gastroenterology Associates of Northern Virginia
mi
from
Fairfax, VA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Gastroenterology Associates of Northern Virginia
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
VCU Medical Center
mi
from
Richmond, VA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated:  2/22/2013
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
Status: Enrolling
Updated:  2/25/2013
Mayo Clinic
mi
from
Jacksonville, FL
Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
Status: Enrolling
Updated: 2/25/2013
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Endoscopic Full Thickness Biopsy, Gastric Wall.
Endoscopic Full Thickness Biopsy of the Gastric Wall in Patients With Refractory Idiopathic Gastroparesis: Pilot Study to Detect Neuromuscular and Immune Pathologic Changes
Status: Enrolling
Updated:  2/25/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Endoscopic Full Thickness Biopsy, Gastric Wall.
Endoscopic Full Thickness Biopsy of the Gastric Wall in Patients With Refractory Idiopathic Gastroparesis: Pilot Study to Detect Neuromuscular and Immune Pathologic Changes
Status: Enrolling
Updated: 2/25/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  2/26/2013
Brigham and Women's Hosp
mi
from
Boston, MA
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 2/26/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
Status: Enrolling
Updated:  2/27/2013
Univ of Massachusetts Med School
mi
from
Worcester, MA
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
Status: Enrolling
Updated: 2/27/2013
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Incentive-based Smoking Cessation for Methadone Patients
Incentive-based Smoking Cessation for Methadone Patients
Status: Enrolling
Updated:  3/7/2013
Substance Abuse Treatment Center, University of Vermont
mi
from
Burlington, VT
Incentive-based Smoking Cessation for Methadone Patients
Incentive-based Smoking Cessation for Methadone Patients
Status: Enrolling
Updated: 3/7/2013
Substance Abuse Treatment Center, University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
University of California, San Francisco
mi
from
San Francisco, CA
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Connecticut Children's Medical Center
mi
from
Hartford, CT
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
University of Maryland Medical Center for Children
mi
from
Baltimore, MD
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
University of Maryland Medical Center for Children
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/12/2013
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/12/2013
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance
Prospective Evaluation of the Clinical Utility of Endoscopically-placed Self Expandable Stents
Status: Enrolling
Updated:  3/13/2013
University of Florida/Shands
mi
from
Gainesville, FL
Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance
Prospective Evaluation of the Clinical Utility of Endoscopically-placed Self Expandable Stents
Status: Enrolling
Updated: 3/13/2013
University of Florida/Shands
mi
from
Gainesville, FL
Click here to add this to my saved trials
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Status: Enrolling
Updated:  3/19/2013
Carolinas Medical Center
mi
from
Charlotte, NC
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Status: Enrolling
Updated: 3/19/2013
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Southern Arizona Limb Salvage Alliance
mi
from
Tucson, AZ
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Southern Arizona Limb Salvage Alliance
mi
from
Tucson, AZ
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Center for Clinical Research, Inc
mi
from
Richmond, CA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Center for Clinical Research, Inc
mi
from
Richmond, CA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Innovative Medical Technologies
mi
from
Los Angeles, CA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Innovative Medical Technologies
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Diabetic Foot and Wound Center
mi
from
Denver, CO
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Diabetic Foot and Wound Center
mi
from
Denver, CO
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Weil Foot & Ankle Institute
mi
from
Des Plaines, IL
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Hines VA Hospital
mi
from
Hines, IL
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Hines VA Hospital
mi
from
Hines, IL
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Cleveland Clinic Foundation
mi
from
Cleveland, OH
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Blair Medical Associates Inc.
mi
from
Altoona, PA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Blair Medical Associates Inc.
mi
from
Altoona, PA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Temple University- School of Podiatric Medicine
mi
from
Philadelphia, PA
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Temple University- School of Podiatric Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated:  3/20/2013
Complete Family Footcare
mi
from
McAllen, TX
The CareFUL Prevention Trial
Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention
Status: Enrolling
Updated: 3/20/2013
Complete Family Footcare
mi
from
McAllen, TX
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Glendale, AZ
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Anaheim, CA
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Aurora, CO
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
New Haven, CT
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Jacksonville, FL
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Roswell, GA
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Joliet, IL
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Joliet, IL
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Indianapolis, IN
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Louisville, KY
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Bethesda, MD
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Boston, MA
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Rochester, MN
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Jackson, MS
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Chesterfield, MO
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Exeter, NH
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Exeter, NH
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Cherry Hill, NJ
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
New York, NY
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Durham, NC
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Cincinnati, OH
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated:  3/21/2013
GSK Investigational Site
mi
from
Weatherford, OK
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Status: Enrolling
Updated: 3/21/2013
GSK Investigational Site
mi
from
Weatherford, OK
Click here to add this to my saved trials